Agree. Stock is under pressure. Even though you get killed in here for saying it.
I don’t mind the CR or the timing of it, and it’s held firm above strike. Management did a decent job and grabbed the cash when they could, incentivising new investors with very attractive pricing and timing.
whether that’s why or not, the fact remains, the stock is now under pressure.
Ann: FDA Approves Sofdra, page-504
-
- There are more pages in this discussion • 51 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
42.3¢ |
Change
0.008(1.81%) |
Mkt cap ! $761.8M | |||
| Open | High | Low | Value | Volume |
| 41.5¢ | 42.5¢ | 41.5¢ | $1.160M | 2.761M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 16 | 427782 | 42.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 42.5¢ | 69319 | 6 |
View Market Depth
| Last trade - 12.16pm 11/09/2024 (20 minute delay) ? |
| BOT (ASX) Chart |